HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mingyao Luo Selected Research

C 684

10/2021Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene.
1/2020Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mingyao Luo Research Topics

Disease

3Thoracic Aorta Dissection
04/2022 - 12/2021
3Thoracic Aortic Aneurysm
02/2022 - 12/2021
2Endoleak
04/2022 - 01/2020
2Inflammation (Inflammations)
02/2022 - 01/2022
2Aortic Aneurysm (Aneurysm, Aortic)
01/2022 - 10/2020
2Marfan Syndrome (Marfan's Syndrome)
10/2021 - 01/2020
2Pulmonary Embolism
01/2021 - 01/2021
1Aortic Rupture
02/2022
1Aortic Dissection
08/2021
1Abdominal Aortic Aneurysm
01/2021
1Pathologic Processes
01/2021
1Thrombophilia
01/2021
1Atherosclerosis
10/2020
1Pathologic Constriction (Stenosis)
10/2020
1Aortic Coarctation
10/2020
1Rupture
10/2020
1Aneurysm (Aneurysms)
10/2018
1Atrioventricular Block
03/2013
1Left Ventricular Outflow Obstruction
03/2013
1Bundle-Branch Block (Fascicular Block)
03/2013

Drug/Important Bio-Agent (IBA)

31,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
02/2022 - 12/2021
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2C 684IBA
10/2021 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2021 - 01/2021
2Pharmaceutical PreparationsIBA
10/2020 - 03/2013
1N- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- methoxyphenyl)- N'- (1- (1,3- thiazole- 2- yl)ethyl)ureaIBA
02/2022
1RNA (Ribonucleic Acid)IBA
02/2022
1Matrix Metalloproteinases (MMPs)IBA
01/2022
1AminopropionitrileIBA
01/2022
1CeramidesIBA
01/2022
1thermozymocidin (myriocin)IBA
01/2022
1LipopolysaccharidesIBA
01/2022
1MetalloproteinsIBA
01/2022
1Actins (F Actin)IBA
12/2021
1Fibrillin-1IBA
10/2021
1ElastinIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1CollagenIBA
01/2021
1Angiotensin IIIBA
01/2021
12-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA
01/2021
1Coenzyme A (CoA)IBA
10/2020
1Transforming Growth Factor-beta Type II ReceptorIBA
10/2018

Therapy/Procedure

3Therapeutics
02/2022 - 12/2021
2Stents
04/2022 - 01/2020
2Endovascular Aneurysm Repair
04/2022 - 08/2021
1Drug Therapy (Chemotherapy)
01/2022
1Ligation
10/2018
1Length of Stay
03/2013
1Intra-Aortic Balloon Pumping
03/2013